Physician

Sudha Y Rani, MD

According to 2025 Medicare claims, Sudha Rani, MD (NPI: 1811916083) practices nephrology in the Lafayette-West Lafayette, IN market, with the plurality of this provider's patient population coming from Tippecanoe, IN. This provider's primary affiliated billing organization is NEPHROLOGY ASSOCIATES OF NORTHERN INDIANA, INC (NPI: 1578505814; TIN: 363683493) and primary practice location at 47905-4972. Rani is affiliated with the Franciscan ACO, Inc. (ACO ID: A2550), Ascension Care Management (ACO ID: A2600), CHSPSC ACO 2, LLC (ACO ID: A3664), Imperium Clinical Partners (ACO ID: A4945), Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403), and Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), participating under the MSSP model.

Rani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 602 traditional Medicare patients, billed 2,109 HCPCS/CPT codes, and received $231,076 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 5,081 prescription claims across 669 beneficiaries totaling $767,063 in drug costs, led by Jardiance (Empagliflozin). 2021 DME data shows 12 claims. Open Payments data shows 25 records totaling $543. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $422,050 and ending at $767,063. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,377 and ending at $2,162.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	833	10,019	$323,086
2016	832	4,887	$311,571
2017	802	3,443	$320,813
2018	817	3,297	$311,245
2019	811	3,224	$318,378
2020	779	3,165	$322,375
2021	729	2,656	$297,881
2022	691	2,440	$279,490
2023	627	2,335	$249,926
2024	602	2,109	$231,076

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	385	3,995	$422,050
2016	434	4,129	$383,898
2017	423	3,589	$556,265
2018	432	3,788	$343,502
2019	473	3,970	$756,652
2020	476	4,086	$984,268
2021	503	4,066	$485,208
2022	509	3,788	$385,185
2023	567	4,150	$465,657
2024	669	5,081	$767,063

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	45	$3,573
2016	N/R	57	$2,580
2017	N/R	56	$1,539
2018	N/R	43	$1,494
2019	N/R	41	$1,966
2020	N/R	22	$1,786
2021	N/R	12	$373
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	77	267	$258
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	85	130	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	414	771	$86
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	104	343	$58
90935	Hemodialysis procedure with physician evaluation	50	174	$52

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	94	6,976	$135,723
Velphoro	Sucroferric Oxyhydroxide	38	1,860	$129,920
Farxiga	Dapagliflozin Propanediol	126	6,196	$111,088
Xphozah	Tenapanor Hcl	16	720	$67,203
Rayaldee	Calcifediol	33	1,230	$58,822

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	25	$543	Vifor Pharma, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sudha Y. Rani, MD?

Tedicare shows public-source Medicare data for Sudha Y. Rani, MD (NPI 1811916083), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sudha Y. Rani, MD have ACO affiliation data?

Sudha Y. Rani, MD is shown with ACO affiliation data for Franciscan ACO, Inc. (MSSP, ACO ID A2550), Ascension Care Management (MSSP, ACO ID A2600), CHSPSC ACO 2, LLC (MSSP, ACO ID A3664), Imperium Clinical Partners (MSSP, ACO ID A4945), Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403), and Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502).

What billing organization is linked to Sudha Y. Rani, MD?

Sudha Y. Rani, MD is linked to NEPHROLOGY ASSOCIATES OF NORTHERN INDIANA, INC (billing NPI 1578505814) in the available physician profile data.

Does Sudha Y. Rani, MD have Open Payments data?

Sudha Y. Rani, MD has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.